Tag

Indian Pharma Market

1 article

RPG Life Sciences Q4 Revenue Up 23.6%

RPG Life Sciences reported Q4 FY26 revenue growth of 23.6% YoY to ₹176.9 crores with EBITDA margin of 25.6%. Domestic Formulations grew 18.2%, outperforming Indian Pharma Market growth of 10.1% in Q4.